Foundation for innovation
in Cardiometabolism and Nutrition

Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles

Nanoscale

Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles

Nos soutiens institutionnels

Notre réseau